European Forecasting Excellence Summit - 20-22 April 2009, Madrid, Spain

Main Category: Pharma Industry / Biotech Industry
Also Included In: Conferences
Article Date: 08 Dec 2008 - 0:00 PDT

email to a friend   printer friendly   opinions  

With the changing healthcare environment, it has never been more essential for organisations to have accurate and first-rate forecasts, to enable strategic business decision-making and stay ahead of the competition. This two day intensive Summit will address the most important aspects of Forecasting and Marketing in Europe. Following on from years of highly successful Global Pharmaceutical Sales conferences eyeforpharma's latest offering in this field guarantees to take forecasting excellence to the next level.

-- Superb networking: Unprecedented opportunities for you to meet, discuss and debate with your peers and the industries most innovative thinkers.

-- Groundbreaking case studies: Cutting edge and insightful case studies from market-leading pharma companies.

-- Interactive roundtables: A series of thought-provoking discussion forums designed to drill down into the business critical issues that matter to you most.

-- In-depth workshops: Unique expert analysis and delegate participation ensuring you take away blueprints for successful sales force strategies.

This information-driven gathering for senior forecasting and marketing executives will draw on the experience of global pharmaceutical companies to give insights into how your forecasting technique can be dramatically enhanced. The summit includes industry led workshops, roundtable discussions, pre-day workshops from ZS Associates and over 25 senior level speakers.

Hosting 25 speakers - key notes include:

-- Nich Guthrie, Head of Forecasting Global Marketing, AstraZeneca
-- Daniel Oertli, Head of Corporate Demand Planning, Merck
-- Kuntal Baveja, Global Head of Forecasting, Novartis
-- Thierry Boutin, Head of Forecasting, sanofi-aventis
-- Richard Murgatroyd, Forecasting Manager, Roche
-- Greg Fazzaro, Director of Finance, Novartis

For more information visit: www.eyeforpharma.com/forecasting09

• Additional
• References
• Citations